Page last updated: 2024-09-03

acetylphenylalanyl-prolyl-boroarginine and dx 9065

acetylphenylalanyl-prolyl-boroarginine has been researched along with dx 9065 in 1 studies

Compound Research Comparison

Studies
(acetylphenylalanyl-prolyl-boroarginine)
Trials
(acetylphenylalanyl-prolyl-boroarginine)
Recent Studies (post-2010)
(acetylphenylalanyl-prolyl-boroarginine)
Studies
(dx 9065)
Trials
(dx 9065)
Recent Studies (post-2010) (dx 9065)
30001700

Protein Interaction Comparison

ProteinTaxonomyacetylphenylalanyl-prolyl-boroarginine (IC50)dx 9065 (IC50)
Coagulation factor XOryctolagus cuniculus (rabbit)0.041
Coagulation factor XHomo sapiens (human)0.085
Trypsin-1Homo sapiens (human)3.2
Trypsin-2Homo sapiens (human)3.2
Alpha-2A adrenergic receptorHomo sapiens (human)0.07
Alpha-2B adrenergic receptorHomo sapiens (human)0.07
Alpha-2C adrenergic receptorHomo sapiens (human)0.07
Translocator proteinHomo sapiens (human)0.07
Trypsin-3Homo sapiens (human)3.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1

Reviews

1 review(s) available for acetylphenylalanyl-prolyl-boroarginine and dx 9065

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000